$9.05 B
Share price
Change (1 day)
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: $9.05 Billion

As of September 2023 Sinopharm has a market cap of $9.05 Billion. This makes Sinopharm the world's 1597th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2023

End of year Market Cap

Year Market cap Change
2023$9.05 B14.01%
2022$7.94 B17.05%
2021$6.78 B-5.92%
2020$7.21 B-33.54%
2019$10.85 B-13.05%
2018$12.48 B4.34%
2017$11.96 B4.95%
2016$11.40 B2.68%
2015$11.10 B13.38%
2014$9.79 B32.88%
2013$7.36 B-1.96%
2012$7.51 B30.31%
2011$5.76 B-26.85%
2010$7.88 B-1.99%
2009$8.04 B

End of Day market cap according to different sources

On Sep 29th, 2023 the market cap of Sinopharm was reported to be:

$9.05 Billion
by Yahoo Finance info icon info icon
$9.05 Billion
by CompaniesMarketCap info icon info icon
$3.89 Billion
by Iex Cloud info icon info icon